Innovaccer stock
Private-market facts for current and former Innovaccer employees researching their stock.
Overview
Healthcare data platform that unifies patient records across providers to enable value-based care, population health management, and care coordination.
Innovaccer outlook
For employees evaluating Innovaccer equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling Innovaccer shares
Why shareholders consider selling
Shareholders in Innovaccer may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Innovaccer does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Innovaccer stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Innovaccer shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Innovaccer shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series E round and its reported $3B valuation can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Innovaccer shareholders
Exploring equity in Innovaccer often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Innovaccer most recently raised a Series E round in February 2022. The company was valued at $3B. Total funding raised to date is approximately $375M.
Lead investors in this round include Tiger Global and General Atlantic.
Founders & company background
Innovaccer was founded in 2014 by Abhinav Shashank, Kanav Hasija, Sandeep Gupta and is headquartered in San Francisco, CA.
Investors
Industry
Similar private companies
Latest Innovaccer news
Frequently asked questions
- Is Innovaccer still a private company?
- Yes, Innovaccer is currently a private company.
- What is Innovaccer's latest funding round?
- Innovaccer's most recent known round is Series E, raised in February 2022.
- What is Innovaccer's valuation?
- Innovaccer's latest reported valuation is $3B.
- Who are the investors in Innovaccer?
- Notable investors include Tiger Global, General Atlantic, Dragoneer Investment Group, ICONIQ Capital, M12 (Microsoft Ventures).
- Can I sell my Innovaccer stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Innovaccer stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Innovaccer data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.